DURECT (NASDAQ:DRRX) Now Covered by Wall Street Zen
Wall Street Zen initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note released on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating on shares of DURECT in a report on Thursday, March 27th. Get Our Latest Stock […]
Wall Street Zen initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note released on Thursday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating on shares of DURECT in a report on Thursday, March 27th. Get Our Latest Stock […]
